Henri Xhakupi

[Europace Editor-in-Chief @EuropaceEiC]

🚨#Europace #epepps

🤔It there a relationship between AF ablation and National income across 🇪🇺european countries❓

🔗🆓https://t.co/Dk7pvCQjgQ
✍️@ItaloPorto2 @HenriXhakupi

@GiulioConte9 @FraSantoroMD @marcovitoloMD @Dominik_Linz @DavideMei93 @AndyZhangMD @LuigiDiBiaseMD

[Henri Xhakupi @HenriXhakupi]

Good luck @AndreaSaglietto

[Andrea Saglietto @AndreaSaglietto]

Grateful for the opportunity to become board member of the "Italian Cardiologist of Tomorrow" @italian_cot. We will do our best!

@enricobaldi88 @Fedeilardi @Albertopolimeni @DomitillaGenti1 @martisetti @saramoscatelli7 @SIC_CARDIOLOGIA #Cardiology

[Andrea Saglietto @AndreaSaglietto]

Very proud for this achievement! We now have a tool (AFA-Recur) to calculate the risk of recurrence after catheter ablation for atrial fibrillation!

See the press release on La Stampa 👇
https://t.co/tzbbxKp6VX

Try the online calculator 👉 https://t.co/0V0SO28Wbh

[Andrea Saglietto @AndreaSaglietto]

Check out our new review on the hemodyamic effect of atrial fibrillation compared to sinus rhythm! 👇

Quite a number of reasons to pursue sinus rhythm maintenance in #AFib patients! 🔥

@mattans5

#EPeeps #sinusbetter #arrhythmology

[Henri Xhakupi @HenriXhakupi]

#MDPIJCDD, #AF, #Omics: Special issue “Omic Approaches to Atrial Fibrillation: Background and Future Perspectives” edited by Prof. Dr. Matteo Anselmino (@mattans5) and Dr. Henri Xhakupi.

📆 15 April 2023

Submit your paper here 👉🏼 https://t.co/WRHKMFYjU7 @GMDeFerrari @JCDD_MDPI